Doughnut-Shaped Spacecraft That Will Float Precious Cargo Back To Earth Successfully Completes First Test Flight
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
The CEO of a key SpaceX rival says customers are drawn to his company because it's 'even-keeled'
Rocket Lab CEO Peter Beck said customers know his company "just builds rockets and satellites." Rocket Lab is a primary rival of Elon Musk's SpaceX. Beck told BI he hadn't seen any "obvious" datapoint on how Musk and Trump's feud is impacting him. As Elon Musk and President Donald Trump continue to butt heads, the CEO of Rocket Lab said that public and private sector customers alike are drawn to his company's stability. "It's fair to say that folks, both government and commercial, come to us and they know that they have a very even-keeled public company that just builds rockets and satellites, and executes against that and nothing else," Peter Beck told Business Insider in June when asked whether the feud between the world's richest man and the president benefited his company. "That becomes valuable to people." Beck added that he hasn't seen any "obvious" data point about the impact of the ongoing disagreement about Trump's spending bill. And, as of mid-June, Beck told BI that Musk hadn't come up more frequently in conversations, either. Representatives for Musk and SpaceX did not respond to a request for comment from BI. Rocket Lab is headquartered in California, though Beck is based in New Zealand. It's an end-to-end space company, meaning it offers launch services, spacecrafts, satellite parts, and on-orbit management. Despite being much smaller than SpaceX — Rocket Lab has about 2,600 employees, Beck said, compared to around 13,000 at SpaceX, according to Forbes — it has emerged as a key rival. Musk himself once called Beck "impressive." Rocket Lab's partially reusable two-stage rocket vehicle, Electron, has completed 67 launches and deployed more than 230 satellites as of the end of June, according to the company. Beck told BI that Neutron, its reusable medium-lift rocket, is scheduled to launch later this year. SpaceX's Falcon 9 currently rules the medium-lift space, having completed almost 500 missions by the end of June. "Right now, there is essentially a pseudo-monopoly on medium lift. I don't think anybody went out intentionally to create that. But nevertheless, that's a status," Beck said. "So we have both government and commercial customers cheering us on very loudly to get Neutron to the pad, because there needs to be some launch site diversification." At the time of writing, Rocket Lab's stock was rising, and the company's market cap was more than $16.8 billion. While SpaceX is a private company, BI reported it was valued at $350 billion at the end of 2024. It's suffered some recent setbacks with its Starship rockets, a successor to the Falcon model — four consecutive launches have blown up, most recently in June. Musk downplayed the latest explosion as "just a scratch," and said the company learns from data collected during failed launches. Some of Musk's companies have suffered due to his public, sometimes ugly, on-again-off-again relationship with Trump, especially Tesla. Polling indicates that Musk's favorability is still underwater, even after he left his government role. Read the original article on Business Insider Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 hours ago
- Yahoo
Stifel Maintains Buy on Vistagen Therapeutics, Inc. (VTGN) Despite PAL-4 Delay
Vistagen Therapeutics, Inc. (NASDAQ:VTGN) is among the best growth stocks to invest in for the next 5 years. Analysts at Stifel reiterated their Buy rating on Vistagen Therapeutics, Inc. (NASDAQ:VTGN) with an unchanged price target of $12.00 post the company's fiscal 2025 announcement. Earlier in the current quarter, the management announced that while the PAL-3 study is in the right direction to present results in the last quarter of 2025, there is a slight delay in the PAL-4 data readout to the first half of the upcoming year. According to the management, the modest delay is associated with the use of enrollment projections from the PAL-2 study, together with the adoption of tight patient selection criteria so that the chances of success could be higher. The company noted that patient demand remains quite strong and is not attributed to this new update. A scientist working in a lab, creating new molecules to treat depression. The research firm firmly believes that Vistagen Therapeutics, Inc. (NASDAQ:VTGN) has 'a credible shot at success in either PAL-3/PAL-4,' which in turn would provide access to what the firm thinks is a large commercial opportunity in social anxiety disorder. Having said that, Stifel analysts maintain a 'relatively low-risk, high-reward bet' on the company. Vistagen Therapeutics, Inc. (NASDAQ:VTGN) is a California-based clinical-stage biopharmaceutical company that focuses on the development and commercialization of therapies for neuropsychiatric and neurological disorders. The core offerings of that company, which was founded in 1998, include Fasedienol(PH94B), Itruvone(PH10), PH80, and PH284. While we acknowledge the potential of VTGN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Sign in to access your portfolio
Forbes
6 hours ago
- Forbes
Bitcoin Price On The Brink As Congress Introduces A New ‘Groundbreaking' Crypto Bill
Bitcoin has surged toward its all-time high in recent weeks, adding around 50% since dropping to its April lows as crypto changes the game for Elon Musk's SpaceX and ChatGPT maker OpenAI. Front-run Donald Trump, the White House and Wall Street by subscribing now to Forbes' CryptoAsset & Blockchain Advisor where you can "uncover blockchain blockbusters poised for 1,000% plus gains!" The bitcoin price, which is braced for a 'big' month ahead after the White House crypto czar teased a major update, has climbed to give bitcoin a total market capitalization of more than $2 trillion, with bullish traders predicting a looming bitcoin price boom. Now, as traders eye 'trillions and trillions' of dollars that remain on the sidelines, bitcoin and crypto-backing senator Senator Cynthia Lummis has introduced a bill to Congress she described as 'groundbreaking.' Sign up now for the free CryptoCodex —A daily five-minute newsletter for traders, investors and the crypto-curious that will get you up to date and keep you ahead of the bitcoin and crypto market bull run Forbes Bitcoin Braced For A Surprise $22 Trillion Fed Price Earthquake By Billy Bambrough U.S. president Donald Trump has declared himself the first "crypto president," helping the bitcoin ... More price soar. AFP via Getty Images 'This groundbreaking legislation is fully paid for, cuts through the bureaucratic red tape and establishes common-sense rules that reflect how digital technologies function in the real world,' Lummis said in a statement. The bill would see small crypto transactions of less than $300 exempt from taxes, as well as crypto lending, and defer taxes on income generated from crypto mining and staking until tokens are sold. It would also apply the typical 30-day wash rule to crypto, removing a loophole that has allowed crypto investors to sell tokens at a loss and then quickly buy them up again while still claiming a tax deduction. Lummis highlighted estimates from the congressional joint committee on taxation that estimated the bill would generate about $600 million through 2034. 'We cannot allow our archaic tax policies to stifle American innovation, and my legislation ensures Americans can participate in the digital economy without inadvertent tax violations,' Lummis said. Lummis had tried to squeeze the crypto tax reforms into U.S. president Donald Trump's so-called "one, big, beautiful" bill but ran out of time before the Senate sent it to the House. Sign up now for CryptoCodex —A free, daily newsletter for the crypto-curious Forbes 'Trillions And Trillions'—Bitcoin Headed For A 'Big' July As Trump And Fed Create Perfect Crypto Price Storm By Billy Bambrough The bitcoin price has rocketed higher over the last year, propelled by U.S. president Donald Trump's ... More return to the White House. Forbes Digital Assets Trump's "one, big, beautiful bill," designed to overhaul the U.S. tax-and-spend landscape and power the country's next phase of growth while adding an expected $3 trillion of debt and raising the debt ceiling by $5 trillion, has been passed by the House of Representatives. House Republicans have meanwhile declared the week beginning July 14 "crypto week," in which policymakers will focus on three major crypto bills—the stablecoin Genius Act, the market structure Clarity Act and the Anti-CBDC [central bank digital currency] Surveillance State Act. The Trump administration's pro-bitcoin and crypto agenda has been named as a catalsyst for a bitcoin price break out in coming months. 'We expect bitcoin to print new all-time highs in the second half of the year, buoyed by growing ETF [exchange-traded fund] and corporate treasury flows, as well as U.S. policy and regulatory developments,' Geoff Kendrick, global head of digital assets research at Standard Chartered Bank, said in an emailed note. Spot bitcoin ETFs, led by the world's largest asset manager BlackRock, as well as so-called bitcoin treasury companies that have sprung up in the wake of Michael Saylor's bitcoin-buying giant Strategy, have hoovered up more than $100 billion worth of bitcoin between them in the last few years.
